Life Science Washington

Thank you to everyone who joined us last night for our latest Executive Insight Series! The event brought together founders and investors for a candid conversation on scaling life science companies and navigating today’s evolving investment landscape.

From raising institutional capital and building leadership teams to preparing for major capital milestones, our speakers shared practical insights on investor readiness, financial positioning, and long-term growth.

Thank you to our partner, Nucleate, and our sponsor, J.P. Morgan, for helping make this program possible.

A special thank you to Sean McClain (Absci) and Michael Fishback (JPMorganChase) for sharing thoughtful, real-world perspectives throughout the discussion.

We’re excited to continue bringing together life science leaders for future Executive Insight Series conversations.

REPORT: Washington state’s life sciences industry has outpaced national life science and state private sector job growth for the fifth consecutive year.

The sector has grown more than 50% over the past decade, supporting over 117,000 jobs in Washington and adding $24.4B to the state’s GDP. Despite hiring slowdowns in Washington and across the country, our life sciences industry has remained strong and continues to lead as a top 10 life sciences cluster in the U.S.

Discover what’s driving this resilience in our latest Economic Impact Report released at Life Science Innovation Northwest 2026:https://lifesciencewa.org/wp-content/uploads/2026/04/2026-Economic-Impact-Report.pdf